The Reactive Oxygen® technology platform is now being developed in a number of pathways, based on a refined and improved formula which is entirely synthetic and has proven to be more potent and stable than the first generation SurgihoneyRO™.
The first synthetic format is a gel known as RO-101®, which is a CE marked medical device intended to replicate the physical and antimicrobial characteristics of SurgihoneyRO™.
Copyright © Matoke Holdings Limited | matokeholdings.com. All rights reserved.
Matoke Holdings Limited, Matoke Holdings Limited logo, Reactive Oxygen, Reactive Oxygen with atom logo, RO and RO with atom logo are all trademarks of Matoke Holdings Limited.
Web Design & Development by Eldo Web Design Ltd